nach oben

PharmacoEconomics

Erschienen in:

01.12.2002 | Review Article

Quality of Life in Patients with Epilepsy and Impact of Treatments

verfasst von: Dr Patrizia Berto

Erschienen in: PharmacoEconomics | Ausgabe 15/2002

Einloggen, um Zugang zu erhalten

Abstract

Epilepsy is a chronic condition with numerous social and psychological consequences. This work aimed to review available data on epilepsy and the impact of surgical and pharmaceutical treatments on the quality of life in adults and children. Research on quality of life in epilepsy is characterised by a wide and fragmentary range of methodology, both in terms of study design and instruments used. Quality of life is worse in patients with epilepsy than in the general population; it is comparable or worse in patients with epilepsy than that in patients with other chronic conditions; and it is similar to that of healthy persons when patients with epilepsy are well-controlled. Frequency of seizures seems to be one of the most relevant determinants of poor quality-of-life (QOL) scores, and quality of life is worsened by the co-existence of depression. The impact of surgical treatment on quality of life is positive, in all ages, in correlation with seizure control. There is no exhaustive or even contradictory results available concerning the impact of drug treatment. Role activities, emotional status and cognition have been the most investigated domains of quality of life in epilepsy research. There is a substantial lack of information regarding the functional status domain.

At present, quality of life and psychosocial functioning in people with epilepsy have been investigated in many studies. Nevertheless, the lack of a standardised approach makes it extremely difficult to summarise and indicate what measures should be used, in which patients, and in which sub-populations. In the pursuit of developing valid, reliable and sensitive measures of quality of life, it seems no longer appropriate to consider seizure frequency alone.

World Health Organisation. Fact Sheet No 166, Revised 2001 Feb. Available from URL: http://www.who.int/inf-fs/en/fact166.html [Accessed 2001 Jul 23]

Perrine K, Kiolbasa T. Cognitive deficits in epilepsy and contribution to psychopathology. Neurology 1999 Sep; 53 Suppl. 2: S39–48PubMed

Hauser WA. Incidence and prevalence. In: Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia (PA): Lippincott-Raven Publishers, 1997: 47–57

Rwiza HT, Kilonzo GP, Haule J, et al. Prevalence and incidence of epilepsy in Ulanga, a rural Tanzanian district: a community-based study. Epilepsia 1992; 33: 1051–6PubMedCrossRef

Begley CE, Annegers JF, Lairson DR, et al. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 1994; 35 (6): 1230–43PubMedCrossRef

Berto P, Tinuper P, Viaggi S, et al. Cost-of-illness of epilepsy in Italy: data from a multicentre observational study (Episcreen). Pharmacoeconomics 2000 Feb; 17 (2): 197–208PubMedCrossRef

Kotsopoulos IA, Evers SM, Ament AJ, et al. Estimating the costs of epilepsy: an international comparison of epilepsy cost studies. Epilepsia 2001 May; 42 (5): 634–40PubMedCrossRef

Kugoh T. Quality of life in adult patients with epilepsy. Epilepsia 1996; 37 Suppl. 3: 37S–40SCrossRef

Schachter SC, Yerby MS. Management in epilepsy: pharmacologic therapy and quality of life issues. Postgrad Med 1987 Feb; 101 (2): 133–53

10.

Duncan J. Medical factors affecting the quality of life in patients with epilepsy. In: Chadwick D, editor. Quality of life and quality of care in epilepsy. London: Royal Society of Medicine, Round Table Series No.23, 1990: 80–7

11.

Thompson PJ, Upton D. Quality of life in family members of persons with epilepsy. In: Trimble MR, Dodson WE, editors. Epilepsy and quality of life. New York: Raven Press Ltd, 1994: 19–31

12.

Wiebe S, Blume WT, Girvin JP, et al. A randomised, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001 Aug 2; 345 (5): 311–9PubMedCrossRef

13.

Vickrey BG, Hays RD, Graber J, et al. A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care 1992 Apr; 30 (4): 299–319PubMedCrossRef

14.

Dodrill C, Batzel LW, Queisser HR, et al. An objective method for the assessment of psychological and social problems among epileptics. Epilepsia 1980; 21: 123–35PubMedCrossRef

15.

Hermann BP. The evolution of health-related quality of life assessment in epilepsy. Qual Life Res 1995; 4 (2): 87–100PubMedCrossRef

16.

Lennox W, Lennox M. Epilepsy and related disorders. Boston: Little, Brown, 1960: Vol 1 and 2

17.

Taylor DC. The components of sickness: disease, illness, and predicaments. Lancet 1979; I: 1008–10CrossRef

18.

Trimble MR, Dodson WE. Preface. In: Trimble MR, Dodson WE, editors. Epilepsy and quality of life. New York: Raven Press Ltd, 1994: xi–xii

19.

Dodson EW, Trimble MR. Epilogue: quality of life in epilepsy. In: Trimble MR, Dodson WE, editors. Epilepsy and quality of life. New York: Raven Press Ltd, 1994: 259–65

20.

Kline Leidy N, Rentz AM, Grace EM. Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy. Epilepsia 1998 Sep; 39 (9): 965–77CrossRef

21.

Dodrill CB, Batzel LW. Issues in quality of life assessment. In: Engel J, Pedley Jr TA, editors. Epilepsy: a comprehensive textbook. Philadelphia (PA): Lippincott-Raven Publishers, 1997: 2227–31

22.

Bergner M. Quality of life, health status and clinical research. Med Care 1989; 27: 148–56CrossRef

23.

Hermann BP. Quality of life in epilepsy. J Epilepsy 1992; 5 (3): 153–65CrossRef

24.

Rosenbaum P, Cadman D, Kirpalani H, et al. Pediatrics: assessing quality of life. In: Spilker B, editor. Quality of life assessments in clinical trials. New York: Raven Press, 1990: 205–15

25.

Shumaker SA, Anderson R, Czajkowski S, et al. Psychological test and scales. In: Spilker B, editor. Quality of life assessments in clinical trials. New York: Raven Press, 1990: 95–113

26.

Ministero della Sanità. Bollettino d’informazione sui farmaci, N.3–4. Rome: Instituto Poligrafico e Zecca dello Stato, 1999: 45–7

27.

Ministero della Sanità. Bollettino d’informazione sui farmaci, N.2. Rome: Instituto Poligrafico e Zecca dello Stato 2000: 36–42

28.

Collings JA. Correlates of well-being in a New Zealand epilepsy sample. N Z Med J 1990; 103 (892): 301–303PubMed

29.

Collings JA. Psychosocial well-being and epilepsy: an empirical study. Epilepsia 1990; 31: 418–26PubMedCrossRef

30.

Jacoby A. Epilepsy and the quality of everyday life: findings from a study of people with well-controlled epilepsy. Soc Sci Med 1992; 34: 657–66PubMedCrossRef

31.

Rausch R, Jacob S, Kraemer S, et al. Gender difference in quality of life as a function of seizure control. Epilepsia 1995; 36 (4 Suppl.): 94S

32.

Reuvekamp HF, Aldenkamp AP, Beun A, et al. Quality of life after epilepsy surgery. Epilepsia 1995; 36 (3 Suppl.): 186S

33.

Hermann BP, Vickrey B, Hays RD, et al. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res 1996 Oct; 25 (2): 113–8PubMedCrossRef

34.

Wagner AK, Bungay KM, Kosinski M, et al. The health status of adults with epilepsy compared with that of people without chronic conditions. Pharmacotherapy 1996 Jan–Feb; 16 (1): 1–9PubMed

35.

Baker GA, Nashef L, van Hout BA. Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life and mortality. Epilepsia 1997; 38 Suppl. 1: 1S–8SCrossRef

36.

Baker GA, Jacoby A, Buck D, et al. Quality of life of people with epilepsy: a European study. Epilepsia 1997; 38 (3): 353–62PubMedCrossRef

37.

Jalava M, Sillanpaa M, Camfield C, et al. Social adjustment and competence 35 years after onset of childhood epilepsy: a prospective controlled study. Epilepsia 1997 Jun; 38 (6): 708–15PubMedCrossRef

38.

Mills N, Bachmann M, Harvey I, et al. Patients’ experience of epilepsy and health care. Fam Pract 1997 Apr; 14 (2): 117–23PubMedCrossRef

39.

Van Hout B, Gagnon D, Souetre E, et al. Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom. Epilepsia 1997; 38 (11): 1221–6PubMedCrossRef

40.

Breier JI, Fuchs KL, Brooschire GA, et al. Quality of life perception in patients with intractable epilepsy or pseudoseizures. Arch Neurol 1998; 55: 660–5PubMedCrossRef

41.

Ribeiro JL, Mendonca D, Martins da Silva A. Impact of epilepsy on QOL in a Portuguese population: exploratory study. Acta Neurol Scand 1998 May; 97 (5): 287–94PubMedCrossRef

42.

Amir M, Roziner I, Knoll A, et al. Self-efficacy and social support as mediators in the relation between disease severity and quality of life in patients with epilepsy. Epilepsia 1999 Feb; 40 (2): 216–24PubMedCrossRef

43.

Buck D, Jacoby A, Baker GA, et al. Cross-cultural differences in health-related quality of life of people with epilepsy: findings from a European study. Qual Life Res 1999; 8 (8): 675–85PubMedCrossRef

44.

Mills N, Bachmann MO, Harvey I, et al. Effect of a primary-care-based epilepsy specialist nurse service on quality of care from the patients’ perspective: quasi-experimental evaluation. Seizure 1999; 8 (1): 1–7PubMedCrossRef

45.

O’Donoghue MF, Goodridge DM, Redhead K. Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract 1999 Mar; 49 (440): 211–4PubMed

46.

Räty L, Hamrin E, Soderfeldt B. Quality of life in newly-debuted epilepsy: an empirical study. Acta Neurol Scand 1999; 100 (4): 221–6PubMedCrossRef

47.

Wiebe S, Bellhouse DR, Fallahay C, et al. Burden of epilepsy: the Ontario Health Survey. Can J Neurol Sci 1999 Nov; 26 (4): 263–70PubMed

48.

Stavem K, Loge JH, Kaasa S. Health status of people with epilepsy compared with a general reference population. Epilepsia 2000 Jan; 41 (1): 85–90PubMedCrossRef

49.

Lehrner J, Kalchmayr R, Serles W, et al. Heath-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 1999; 8: 88–92PubMedCrossRef

50.

Wiegartz P, Seidenberg M, Woodard A, et al. Co-morbid psychiatric disorder in chronic epilepsy: recognition and aetiology of depression. Neurology 1999 Sep 22; 53 Suppl. 2: 3S–8S

51.

Hoare P. The quality of life of children with epilepsy and their families. Seizure 1993; 2: 269–75PubMedCrossRef

52.

Austin JK, Smith MS, Risinger MW, et al. Childhood epilepsy and asthma: comparison of quality of life. Epilepsia 1994 May–Jun; 35 (3): 608–15PubMedCrossRef

53.

Mitchell WG, Scheier LM, Baker SA. Psychosocial, behavioural, and medical outcomes in children with epilepsy: a developmental risk factor model using longitudinal data. Paediatrics 1994; 94 (4): 471–7

54.

Austin JK, Huster GA, Dunn DW, et al. Adolescents with active or inactive epilepsy or asthma: a comparison of quality of life. Epilepsia 1996 Dec; 37 (12): 1228–38PubMedCrossRef

55.

Carpay HA, Vermeulen J, Stroink H, et al. Disability due to restrictions in childhood epilepsy. Dev Med Child Neurol 1997; 39 (8): 521–6PubMedCrossRef

56.

Norrby U, Carlsson J, Beckung E, et al. Self-assessment of well-being in a group of children with epilepsy. Seizure 1999 Jun; 8 (4): 228–34PubMedCrossRef

57.

Sabaz M, Cairns DR, Lawson J, et al. The health-related quality of life of children with refractory epilepsy: a comparison of those with and without intellectual disability. Epilepsia 2001; 45 (5): 621–8CrossRef

58.

Wagner AK, Bungay KM, Bromfield E, et al. Relationship of health-related quality of life seizure control and antiepileptic drug adverse effects. Epilepsia 1994; 35 (8 Suppl.): 56S

59.

Banks GK, McCaughey L, Beran R, et al. Influence of antiepileptic medication on cognitive and social behaviour in quality of life outcomes. Epilepsia 1995; 36 (3 Suppl.): 171S

60.

Dimond KR, Pande AC, Lamoreaux L, et al. Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy [published erratum appears in Prog Neuropsychopharmacol Biol Psychiatry 1996 Aug; 20 (6): 1081]. Prog Neuropsychopharmacol Biol Psychiatry 1996 Apr; 20 (3): 407–17PubMedCrossRef

61.

Mortimore C, Trimble M, Emmers E. Effects of gabapentin on cognition and quality of life in patients with epilepsy. Seizure 1998 Oct; 7 (5): 359–64PubMedCrossRef

62.

Bruni J. Gabapentin as adjunctive therapy for partial seizures. Epilepsia 1999; 40 Suppl. 6: 27S–8SCrossRef

63.

Dodrill CB, Arnett JL, Hayes AG, et al. Cognitive abilities and adjustment with gabapentin: results of a multisite study. Epilepsy Res 1999 Jun; 35 (2): 109–21PubMedCrossRef

64.

Mayer T, Schutte W, Wolf P, et al. Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study. Acta Neurol Scand 1999 Jan; 99 (1): 1–7PubMedCrossRef

65.

Lindberger M, Alenius M, Frisen L, et al. Gabapentin versus vigabatrin as first add-on patients with partial seizures that failed to respond monotherapy: a randomised, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment. Epilepsia 2000 Oct; 41 (10): 1289–95PubMedCrossRef

66.

Smith D, Baker G, Davies G, et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993; 34 (2): 312–22PubMedCrossRef

67.

Selai CE, Smith K, Trimble MR. Adjunctive therapy in epilepsy: a cost-effectiveness comparison of two AEDs. Seizure 1999 Feb; 8 (1): 8–13PubMedCrossRef

68.

Steiner TJ, Dellaportas CI, Findley LJ, et al. Lamotrigine in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 1999 May; 40 (5): 601–7PubMedCrossRef

69.

Gillham R, Kane K, Bryant-Comstock L. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy wioth health-related quality of life as an outcome measure. Seizure 2000 Sep; 9 (6): 375–9PubMedCrossRef

70.

Dodrill CB, Arnett JL, Sommerville KW, et al. Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy. Neurology 1993 Dec; 43 (12): 2501–7PubMedCrossRef

71.

Dodrill CB, Arnett JL, Sommerville KW, et al. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Epilepsia 1995 Feb; 36 (2): 164–73PubMedCrossRef

72.

Provinciali L, Bartolini M, Mari F, et al. Influence of vigabatrin on cognitive performances and behaviour in patients with drug-resistant epilepsy. Acta Neurol Scand 1996 Jul; 94 (1): 12–8PubMedCrossRef

73.

Dodrill CB, Arnett JL, Sommerville KW, et al. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology 1997 Apr; 48 (4): 1025–31PubMedCrossRef

74.

Dodrill CB, Arnett JL, Shu V, et al. Effects of tiagabine monotherapy on abilities, adjustment and mood. Epilepsia 1998 Jan; 39 (1): 33–42PubMedCrossRef

75.

Petersen B, Walker ML, Runge U, et al. Quality of life in patients with idiopathic, generalized epilepsy. J Epilepsy 1998; 11 (6): 306–13CrossRef

76.

Cramer JA, Arrigo C, Van Hammee G, et al. Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group. Epilepsia 2000 Jul; 41 (7): 868–74PubMedCrossRef

77.

Stavem K, Kloster R, Rossberg E, et al. Acupuncture in intractable epilepsy: lack of effect on health-related quality of life. Seizure 2000 Sep; 9 (6): 422–6PubMedCrossRef

78.

Seidman-Ripley JG, Bound VK, Andermann F, et al. Psychosocial consequences of postoperative seizure relief. Epilepsia 1993 Mar–Apr; 34 (2): 248–54PubMedCrossRef

79.

Mihara T, Inoue Y, Watanabe Y, et al. Improvement of quality-of-life following resective surgery for temporal lobe epilepsy: results of patient and family assessments. Jpn J Psychiatry Neurol 1994 Jun; 48 (2): 221–9PubMed

80.

Vickrey BG, Hays RD, Rausch R, et al. Quality of life of epilepsy surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or depressive symptoms. Epilepsia 1994 May–Jun; 35 (3): 597–607PubMedCrossRef

81.

Vickrey BG, Hays RD, Rausch R, et al. Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery. Lancet 1995 Dec 2; 346 (8988): 1445–9PubMedCrossRef

82.

Kellett MW, Smith DF, Baker GA, et al. Quality of life after epilepsy surgery. J Neuro Neurosurg Psychiatry 1997; 63: 52–8CrossRef

83.

Malmgren K, Sullivan M, Ekstedt G, et al. Health-related quality of life after epilepsy surgery: a Swedish multicenter study. Epilepsia 1997; 38: 830–8PubMedCrossRef

84.

McLachlan RS, Rose KJ, Derry PA, et al. Health-related quality of life and seizure control in temporal lobe epilepsy. Can Ann 1997; 41 (4): 482–9

85.

Gilliam F, Kuzniecky R, Meador K, et al. Patient-orientated outcome assessment after temporal lobecotmy for refractory epilepsy. Neurology 1999 Sep 11; 53 (4): 687–94PubMedCrossRef

86.

Markand ON, Salanova V, Whelihan E, et al. Health-related quality of life outcome in medically refractory epilepsy treated with anterior temporal lobectomy. Epilepsia 2000 Jun; 41 (6): 749–59PubMedCrossRef

87.

Selai CE, Elsner K, Trimlbe MR. Quality of life pre and post epilepsy surgery. Epilepsy Res 2000; 38: 67–74PubMedCrossRef

88.

Sirven JI, Sperling M, Naritoku D, et al. Vagus nerve stimulation therapy for epilepsy in older adults. Neurology 2000 Mar 14; 54 (5): 1179–82PubMedCrossRef

89.

Gilliam F, Wyllie E, Kashden J, et al. Epilepsy surgery outcome: comprehensive assessment in children. Neurology 1997; 48 (5): 1368–74PubMedCrossRef

90.

Keene D, Higgins MJ, Ventureyra EG. Outcome and life prospects after surgical management of medically intractable epilepsy in patients under 18 years of age. Childs Nerv Syst 1997; 13: 530–5PubMedCrossRef

91.

Battaglia D, Di Rocco C, Iuvone L, et al. Neuro-cognitive development and epilepsy outcome in children with surgically treated hemimegalencephaly. Neuropediatrics 1999; 30 (6): 307–13PubMedCrossRef

92.

Lundgren J, Amark P, Blennow G, et al. Vagus nerve stimulation in 16 children with refractory epilepsy. Epilepsia 1998 Aug; 39 (8): 809–13PubMedCrossRef

93.

Patwardhan RV, Stong B, Bebin EM, et al. Efficacy of vagal nerve stimulation in children with medically refractory epilepsy. Neurosurgery 2000 Dec; 47 (6): 1353–8PubMedCrossRef

94.

Kendrick AM, Trimble MR. Repertory Grid in the assessment of quality of life in patients with epilepsy: the quality of life assessment schedule. In: Trimble MR, Dodson WE, editors. Epilepsy and quality of life. New York: Raven Press Ltd, 1994: 19–31

95.

Collings JA. Epilepsy and well-being. Soc Sci Med 1990; 31: 165–70PubMedCrossRef

96.

Baker GA. Improved quality of life as an outcome of antiepileptic drug therapy: is it enough? CNS Drugs 1995; 3 (5): 323–7CrossRef

97.

Baker GA, Amrson AG. Cognitive and behavioural assessments in clinical trials: what measure? Epilepsy Res 2001 May; 45 (1–3): 163–7PubMedCrossRef

Titel: Quality of Life in Patients with Epilepsy and Impact of Treatments
verfasst von: Dr Patrizia Berto
Publikationsdatum: 01.12.2002
Verlag: Springer International Publishing
Erschienen in: PharmacoEconomics / Ausgabe 15/2002
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI: https://doi.org/10.2165/00019053-200220150-00002

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Quality of Life in Patients with Epilepsy and Impact of Treatments

Abstract

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten